Phase to Phase - The Guide to Drug Development

By Life Sciences Pennsylvania (other events)

Friday, October 7 2022 9:00 AM 10:00 AM EST

*THIS SESSION WILL BE PRESENTED DURING THE LIFE SCIENCES FUTURE - BIOPHARM CONFERENCE.* If you would like to view the full conference, please register using the link here -


Phase to Phase - The Guide to Drug Development

FlowMetric’s expertise includes Discovery / Lead Optimization, Pre-clinical Tox, Translational, and Clinical Trials.

Session Topic – Discovery: The do’s and don’t’s, experience perspective, and recognition of workarounds that enable the process. 

  • Target Identification
  • Target Validation
  • Hit Identification/Lead Discovery
  • Assay Development
  • Lead Optimization


  • Mark Tornetta, MS, Vice President of Lead Discovery, Tavotek Biotherapeutics
  • Julie Bick, Ph.D., Chief Scientific Officer, FlowMetric, a KCAS company  
  • Dominic Warrino, Ph.D., Senior Scientific Adviser, KCAS Bioanalytical & Biomarker Services
  • Moderator: Ren Capocasale, Vice Chair & Founder, FlowMetric, a KCAS company


Refund/cancellation policy: This program is offered free of charge. As such refunds are not applicable. Questions: Contact Lauren Boyle, [email protected]

Life Sciences Pennsylvania

Mailing Address

411 Swedeland Road, Suite 23-1080, King of Prussia, PA 19406